| 論文名 |
Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system. |
| 著者 |
McCarthy J
O'Neill MJ
Bourre L
Walsh D
Quinlan A
Hurley G
Ogier J
Shanahan F
Melgar S
Darcy R
O'Driscoll CM
|
| キーワード |
|
| 出版年月 |
1970年1月 |
| 発表先 |
J Control Release. 2013 May 28;168(1):28-34. |
| WEBサイト |
|
| 論文概要（和文） |
改変されたシクロデキストリン送達システムを用いた急性大腸炎のマウスモデルにおけるTNF-αの遺伝子サイレンシング。 |
| 論文概要（英文） |
Inflammatory bowel disease (IBD) is a chronic relapsing inflammation of the gastrointestinal tract. The cytokine TNF-alpha (TNF-α) plays a pivotal role in mediating this inflammatory response. RNA interference (RNAi) holds great promise for the specific and selective silencing of aberrantly expressed genes, such as TNF-α in IBD. The aim of this study was to investigate the efficacy of an amphiphilic cationic cyclodextrin (CD) vector for effective TNF-α siRNA delivery to macrophage cells and to mice with induced acute-colitis. The stability of CD.siRNA was examined by gel electrophoresis in biorelevant media reflecting colonic fluids. RAW264.7 cells were transfected with CD.TNF-α siRNA, stimulated with lipopolysaccharide (LPS) and TNF-α and IL-6 responses were measured by PCR and ELISA. Female C57BL/6 mice were exposed to dextran sodium sulphate (DSS) and treated by intrarectal administration with either CD.siRNA TNF-α or a control solution. In vitro, siRNA in CD nanocomplexes remained intact and stable in both fed and fasted simulated colonic fluids. RAW264.7 cells transfected with CD.TNF-α siRNA and stimulated with LPS displayed a significant reduction in both gene and protein levels of TNF-α and IL-6. CD.TNF-α siRNA-treated mice revealed a mild amelioration in clinical signs of colitis, but significant reductions in total colon weight and colonic mRNA expression of TNF-α and IL-6 compared to DSS-control mice were detected. This data indicates the clinical potential of a local CD-based TNF-α siRNA delivery system for the treatment of IBD. |
